GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family

[Image: see text] Pan-BET inhibitors have shown profound efficacy in a number of in vivo preclinical models and have entered the clinic in oncology trials where adverse events have been reported. These inhibitors interact equipotently with the eight bromodomains of the BET family of proteins. To bet...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ACS Med Chem Lett
Auteurs principaux: Preston, Alex, Atkinson, Stephen J., Bamborough, Paul, Chung, Chun-wa, Gordon, Laurie J., Grandi, Paola, Gray, James R. J., Harrison, Lee A., Lewis, Antonia J., Lugo, David, Messenger, Cassie, Michon, Anne-Marie, Mitchell, Darren J., Prinjha, Rab K., Rioja, Inmaculada, Seal, Jon, Taylor, Simon, Thesmar, Pierre, Wall, Ian D., Watson, Robert J., Woolven, James M., Demont, Emmanuel H.
Format: Artigo
Langue:Inglês
Publié: American Chemical Society 2020
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7429977/
https://ncbi.nlm.nih.gov/pubmed/32832027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.0c00247
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires